This fact sheet highlights key findings from AURA 2023 and information about antimicrobial stewardship (AMS) and antimicrobial resistance (AMR), to support pharmacists working across primary and acute care settings.
This fact sheet highlights key findings from AURA 2023 and priorities for action to support infection prevention and control clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.
This fact sheet highlights key findings from AURA 2023 and priorities for action to support aged care services and clinicians prevent and control antimicrobial resistance (AMR) and improve antimicrobial use.
From 1 January 2024 the Commission will standardise requirements for repeat assessments for general practices under the NGPA Scheme.
The National Medicines Symposium 2025 was held on 22 October and delved into the safe and appropriate use of medicines in people with diabetes.
Consultation is now open on the draft Chronic Obstructive Pulmonary Disease (COPD) Clinical Care Standard, which describes the care that people living with COPD should expect to receive, including for COPD exacerbations.
To inform imaging practices of the revision of the national diagnostic reference levels (DRLs) for nuclear medicine and positron emission tomography (PET).
The advisory clarifies how diagnostic imaging practices apply Standard 2.4 Medication Management when imaging occurs in association with a surgical or interventional procedure.
The advisory clarifies the required evidence for Standard 3.2, Optimised Radiation Technique Charts.
The advisory provides information about the use of attestation letters as evidence of an equipment service provider’s qualifications, training, and licencing.